Your browser doesn't support javascript.
loading
Cryptic activation of an Irf8 enhancer governs cDC1 fate specification.
Durai, Vivek; Bagadia, Prachi; Granja, Jeffrey M; Satpathy, Ansuman T; Kulkarni, Devesha H; Davidson, Jesse T; Wu, Renee; Patel, Swapneel J; Iwata, Arifumi; Liu, Tian-Tian; Huang, Xiao; Briseño, Carlos G; Grajales-Reyes, Gary E; Wöhner, Miriam; Tagoh, Hiromi; Kee, Barbara L; Newberry, Rodney D; Busslinger, Meinrad; Chang, Howard Y; Murphy, Theresa L; Murphy, Kenneth M.
Afiliação
  • Durai V; Department of Pathology and Immunology, Washington University in St Louis, School of Medicine, St Louis, MO, USA.
  • Bagadia P; Department of Pathology and Immunology, Washington University in St Louis, School of Medicine, St Louis, MO, USA.
  • Granja JM; Center for Personal Dynamic Regulomes, Stanford University School of Medicine, Stanford, CA, USA.
  • Satpathy AT; Deparment of Genetics, Stanford University School of Medicine, Stanford, CA, USA.
  • Kulkarni DH; Biophysics Program, Stanford University School of Medicine, Stanford, CA, USA.
  • Davidson JT; Center for Personal Dynamic Regulomes, Stanford University School of Medicine, Stanford, CA, USA.
  • Wu R; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.
  • Patel SJ; Division of Gastroenterology, John T. Milliken Department of Medicine, Washington University in St Louis, School of Medicine, St Louis, MO, USA.
  • Iwata A; Department of Pathology and Immunology, Washington University in St Louis, School of Medicine, St Louis, MO, USA.
  • Liu TT; Department of Pathology and Immunology, Washington University in St Louis, School of Medicine, St Louis, MO, USA.
  • Huang X; Division of Rheumatology, John T. Milliken Department of Medicine, Washington University in St Louis, School of Medicine, St Louis, MO, USA.
  • Briseño CG; Department of Pathology and Immunology, Washington University in St Louis, School of Medicine, St Louis, MO, USA.
  • Grajales-Reyes GE; Department of Pathology and Immunology, Washington University in St Louis, School of Medicine, St Louis, MO, USA.
  • Wöhner M; Howard Hughes Medical Institute, Washington University in St Louis, School of Medicine, St Louis, MO, USA.
  • Tagoh H; Department of Pathology and Immunology, Washington University in St Louis, School of Medicine, St Louis, MO, USA.
  • Kee BL; Department of Pathology and Immunology, Washington University in St Louis, School of Medicine, St Louis, MO, USA.
  • Newberry RD; Department of Pathology and Immunology, Washington University in St Louis, School of Medicine, St Louis, MO, USA.
  • Busslinger M; Research Institute of Molecular Pathology, Campus-Vienna-Biocenter 1, Vienna, Austria.
  • Chang HY; Research Institute of Molecular Pathology, Campus-Vienna-Biocenter 1, Vienna, Austria.
  • Murphy TL; Department of Pathology and Committee on Immunology, University of Chicago, Chicago, IL, USA.
  • Murphy KM; Division of Gastroenterology, John T. Milliken Department of Medicine, Washington University in St Louis, School of Medicine, St Louis, MO, USA.
Nat Immunol ; 20(9): 1161-1173, 2019 09.
Article em En | MEDLINE | ID: mdl-31406378
ABSTRACT
Induction of the transcription factor Irf8 in the common dendritic cell progenitor (CDP) is required for classical type 1 dendritic cell (cDC1) fate specification, but the mechanisms controlling this induction are unclear. In the present study Irf8 enhancers were identified via chromatin profiling of dendritic cells and CRISPR/Cas9 genome editing was used to assess their roles in Irf8 regulation. An enhancer 32 kilobases (kb) downstream of the Irf8 transcriptional start site (+32-kb Irf8) that was active in mature cDC1s was required for the development of this lineage, but not for its specification. Instead, a +41-kb Irf8 enhancer, previously thought to be active only in plasmacytoid dendritic cells, was found to also be transiently accessible in cDC1 progenitors, and deleting this enhancer prevented the induction of Irf8 in CDPs and abolished cDC1 specification. Thus, cryptic activation of the +41-kb Irf8 enhancer in dendritic cell progenitors is responsible for cDC1 fate specification.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Células Dendríticas / Monócitos / Elementos Facilitadores Genéticos / Fatores Reguladores de Interferon / Macrófagos Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Nat Immunol Assunto da revista: ALERGIA E IMUNOLOGIA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Células Dendríticas / Monócitos / Elementos Facilitadores Genéticos / Fatores Reguladores de Interferon / Macrófagos Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Nat Immunol Assunto da revista: ALERGIA E IMUNOLOGIA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos